Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 200152.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Best
100%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 2.65 0.26 0.26
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -379.26 -86.54 -18.06
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -6.47 -20.78 -19.52
Cash 11.94 9.68 8.64
Capex 79.54 -0.32 -1.55
Free Cash Flow 72.91 -1.50 -5.53
Revenue 161.88 9.73 3.72
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 94.59 -0.05 -0.96
Operating Margin 87.84 -0.13 -1.09
ROA 69.85 -0.02 -0.05
ROE -72.13 0.06 0.20
ROIC 67.39 -0.02 -0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 200152.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 200152.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 200152.SZ is permitted for members.